Brand-name vs compounded
SnagRx vs Ro.co: Brand-Name or Compounded? (2026)
Compare SnagRx and Ro.co on real cost over 12 months, medication type, price stability and support. Independent 2026 analysis, no first-month gimmicks.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.3 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Both SnagRx and Ro.co will get a GLP-1 prescription to your door without an in-person visit. The question is what the year after that first shipment looks like.
Choosing between them is really choosing between an approved finished drug and a compounded preparation. Ro.co sits on one side of that line and SnagRx on the other, and no amount of feature comparison makes the distinction go away.
What follows is a like-for-like read of both programs: entry pricing, maintenance pricing, formulary, support model and the terms attached to each. Every figure traces back to the provider's own published material, and the missing ones stay missing.
The short answer
- Lowest ongoing rate
- Ro.co — $39/mo against $99/mo, though only one of the two publishes enough to total a full year.
- FDA-approved medication
- Ro.co — FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables — a finished product the FDA has reviewed, rather than a compounded preparation.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Most support included
- Ro.co — Established full-service platform with clinician oversight.
SnagRx vs Ro.co: the specification
Every figure below is the provider's own published number. The blank spaces are theirs, not ours.
| SnagRx | Ro.co | |
|---|---|---|
| Advertised price | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan | Get started online for $39 |
| Rate after promotions | $99/mo | $39/mo |
| Pricing structure | Flat rate at every dose | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables |
| State coverage | 48 states | Not published |
| How fast you start | 5-minute intake, clinician review typically within 5 hours and always within 24 | Online consultation |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| Patient reviews | 9,860 | 40,215 |
| eRxDoctor score | 7.5/10 | 7.3/10 |
SnagRx vs Ro.co on total cost, not entry price
Trial data runs to 68 and 72 weeks; the pricing people compare runs to 30 days. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| SnagRx | Ro.co | |
|---|---|---|
| First month | $99 | $39 |
| Months 2 onward | $99/mo | Not published |
| 6-month total | $594 | Not computable |
| 12-month total | $1,188 | Not computable |
| Best published plan | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr | No multi-month discount published |
A like-for-like annual total is not available for Ro.co: ongoing medication pricing varies by plan and is set after the consultation. Treat any comparison that quotes one as an estimate someone else has made for you.
What is actually in the vial
Ro.co supplies FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables. A brand-name GLP-1 is a finished drug the FDA has reviewed for safety, efficacy and manufacturing quality, and every vial or pen is the same product made to the same specification.
SnagRx works with compounded semaglutide and compounded tirzepatide. Compounding is what puts $99/mo within reach; it also means no approval application stands behind the specific product you receive.
This is the decision to make deliberately rather than by price. If the regulatory status of what you are injecting weekly matters to you, that settles it toward Ro.co; if cost is the barrier that has kept you from treating at all, SnagRx exists for a reason.
SnagRx in detail
SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping.
The process is 5-minute intake, clinician review typically within 5 hours and always within 24, then free next-day UPS or FedEx in temperature-controlled packaging. On money, expect flat rate at every dose — published upfront.
What continues after the first shipment: 1:1 nursing staff plus a secure patient portal for refills and dose changes. Formulary: compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Price locked flat at every dose and at renewal — no re-pricing during titration
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
- States LegitScript certification, which patients can verify independently
- Names its four US 503A partner pharmacies and its clinician network (OpenLoop Health)
SnagRx cons
- Clinician network covers 48 states, not all 50
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
Set beside Ro.co, the thing to weigh: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
How Ro.co works
Ro.co positions itself on the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all. Get Started Online for Just $39
Getting started means online consultation, after which home delivery. Pricing runs on a promotional first month, then standard rate basis, partly published.
Established full-service platform with clinician oversight. The formulary covers FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables.
Ro.co pros
- No hidden fees; pricing disclosed before you complete your consultation
- Only mainstream platform offering the FDA-approved Wegovy pill, oral GLP-1, no injections
- Get started online for just $39
- FDA-approved finished medication, not compounded
Ro.co cons
- Ongoing medication pricing varies and can be high depending on the plan
- Branded and FDA-approved medications cost significantly more than compounded alternatives
- Less price-competitive than compounded-only platforms for budget-driven patients
Where it gives ground to SnagRx: an FDA-approved finished medication costs multiples of a compounded vial.
Picking between them
Choose SnagRx if:
- you want the full price in front of you before completing an intake
- you are willing to commit for a term in exchange for a lower effective rate (12-month semaglutide plan at $69/mo ($828 a year))
- you want the price you sign up at to survive titration
- you want tirzepatide available without changing provider later
Choose Ro.co if:
- you would get real value from the only mainstream platform here offering the FDA-approved Wegovy pill, so no injections at all
- you would rather use the platform with the longer public record (40,215 reviews)
- you want an FDA-approved finished medication rather than a compounded preparation
- the monthly rate is the constraint — $39/mo against $99/mo
Where each program concedes something
On price. The monthly gap is 2.5x in Ro.co's favor. Whether that is a saving or a false economy turns on one thing: an FDA-approved finished medication costs multiples of a compounded vial.
On commitment. SnagRx rewards a longer commitment (12-month semaglutide plan at $69/mo ($828 a year)), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On predictability. The pricing structures differ (flat rate at every dose versus promotional first month, then standard rate), and structure, not headline rate, determines the twelve-month bill.
On access. SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24 and free next-day UPS or FedEx in temperature-controlled packaging; Ro.co advertises online consultation and home delivery. Coverage differs too — 48 states against not published — which decides the question before price does if you are in a restricted state.
What the evidence actually says
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
SnagRx vs Ro.co: common questions
Does the price go up as my dose increases?
At SnagRx, no — the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. At Ro.co, the published structure is promotional first month, then standard rate. Since GLP-1 doses escalate over the first months, that difference is worth more than most feature comparisons.
Is Ro.co cheaper than SnagRx?
Yes, on the ongoing rate. Ro.co runs $39/mo once promotional pricing ends, against $99/mo at SnagRx — a difference of 2.5x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
How fast can I start with SnagRx compared with Ro.co?
SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24, with free next-day UPS or FedEx in temperature-controlled packaging. Ro.co advertises online consultation, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do SnagRx and Ro.co prescribe the same medication?
No. SnagRx dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application; Ro.co dispenses brand-name, FDA-approved finished medication. That is a regulatory difference rather than a branding one, and it is the main reason the two prices are not directly comparable.
Can I switch from SnagRx to Ro.co later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
Does SnagRx or Ro.co offer tirzepatide?
SnagRx does, at $149/mo. Ro.co publishes FDA-approved Wegovy pill (oral GLP-1) and brand-name GLP-1 injectables only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
What happens if I stop taking the medication?
Weight regain is the documented pattern, and it is not specific to either platform. Trial extension data has recorded participants regaining most of the weight they lost within a year of stopping semaglutide. Both SnagRx and Ro.co price on a monthly basis, so treat the twelve-month figure as the realistic commitment rather than a first-month experiment.
The verdict
Ro.co is the cheaper of the two to run at $39/mo, but a full-year total is only computable for one side of this comparison, so treat that as a directional finding rather than a settled one.
SnagRx's case is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly; its cost: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Enhance MD vs SnagRxBudget vs premium
- Directmeds vs SnagRxPublished price vs quote-only
- Directmeds vs Ro.coBrand-name vs compounded
- Enhance MD vs Ro.coBrand-name vs compounded
- Hers vs He & She MDBrand-name vs compounded
- Hers vs MaximusBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by SnagRx or Ro.co, and does not sell treatment. Read our ranking methodology.